Recent Quotes

My Watchlist

Indicators

Apollomics Inc. - Class A Ordinary Shares (NQ: APLM )

9.750 +0.380 (+4.06%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	194,297
Open	8.650
Bid (Size)	9.230 (1)
Ask (Size)	13.00 (9)
Prev. Close	9.370
Today's Range	7.620 - 10.50
52wk Range	6.500 - 105.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

December 10, 2024

From Apollomics Inc.

Via GlobeNewswire

(APLM) - Analyzing Apollomics's Short Interest

December 03, 2024

Via Benzinga

Performance

YTD	-89.39%	-89.39%
1 Month	-3.47%	-3.47%
3 Month	-24.07%	-24.07%
6 Month	-55.68%	-55.68%
1 Year	-88.11%	-88.11%

More News

Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

November 21, 2024

From Apollomics Inc.

Via GlobeNewswire

What's Going On With Apollomics (APLM) Stock Exploding Higher?

July 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

November 19, 2024

Via Benzinga

Dow Dips Over 300 Points; Walmart Raises FY25 Forecast

November 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session

November 18, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

November 18, 2024

Via Benzinga

Dow Falls 100 Points; Brady Posts Upbeat Results

November 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session

September 30, 2024

Via Benzinga

Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

September 16, 2024

From Apollomics Inc.

Via GlobeNewswire

Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 04, 2024

From Apollomics Inc.

Via GlobeNewswire

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

August 14, 2024

From Apollomics Inc.

Via GlobeNewswire

S&P 500 Gains 1%; Home Depot Earnings Top Views

August 13, 2024

Via Benzinga

Why Is Penny Stock Apollomics Trading Higher On Tuesday?

August 13, 2024

Via Benzinga

Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July

August 13, 2024

Via Benzinga

Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial

August 13, 2024

From Apollomics Inc.

Via GlobeNewswire

Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference

August 08, 2024

From Apollomics Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

July 18, 2024

Via InvestorPlace

Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket

July 18, 2024

Via Benzinga

Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

July 16, 2024

From Apollomics Inc.

Via GlobeNewswire

Apollomics Announces Updated Strategic Focus and Leadership Team Changes

July 03, 2024

From Apollomics Inc.

Via GlobeNewswire

Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

June 04, 2024

From Apollomics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session

May 29, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.